Biotech/Biomedical
News Category

Earth Science Tech Uplists to OTCQB, Acquires Meduvo and Zoolzy, and Reports Strong Q1 Fiscal 2027 Results
Earth Science Tech's uplisting to OTCQB, strategic acquisitions, and robust financial performance highlight its growth trajectory and potential for fu...

AI Maverick Intel to Acquire Heal Access Canada in $5 Million Deal, Eyes AI Healthcare Expansion
AI Maverick Intel Inc. has signed a definitive agreement to acquire Heal Access Canada Inc., an AI healthcare technology company, in a transaction tha...

Oncotelic's PDAOAI Platform and HCC Research Signal New Direction for AI-Driven Drug Discovery
Oncotelic Therapeutics unveiled its PDAOAI discovery platform and a four-gene HCC signature at Drug Discovery 2026, highlighting how AI-powered litera...

Experimental Vaccine Shows Promise in Glioblastoma Trial, Signaling Renewed Hope After Decades of Stagnation
A new experimental vaccine has extended survival in glioblastoma patients, particularly those under 65, offering a potential breakthrough in a field t...

HeartBeam Joins European Cardiovascular Consortium to Lead HEART-CHECK Study
HeartBeam Inc. has joined a European consortium to lead the HEART-CHECK study, evaluating its portable ECG system for early detection of cardiac event...

Helus Pharma Adds CNS Drug Development Veteran Suresh Durgam to Board of Directors
Helus Pharma appoints Suresh Durgam, a veteran with over 20 years in CNS drug development, to its board, a move that could accelerate its late-stage p...

ECGI Holdings Completes Avanta Group Acquisition, Shifts Primary Focus to Healthcare
ECGI Holdings has completed its acquisition of Avanta Group, pivoting the company toward healthcare services and AI-driven technology and potentially ...

Tonix Pharmaceuticals to Present TNX-801 Vaccine Platform at World Vaccine Congress Europe
Tonix Pharmaceuticals will present its TNX-801 horsepox-based vaccine platform at a major European vaccine conference, highlighting a potential new to...

OrthodontiCell Secures Capital to Complete Testing for Planned U.S. Phase II Pivotal Study
OrthodontiCell has secured sufficient capital to complete the remaining testing needed to support its application to begin a planned Phase II pivotal ...

Lee Lorenzen Argues Better Measurement, Not New Discoveries Alone, Drives Scientific Progress
Researcher Lee Lorenzen contends that improved scientific measurement tools are as crucial as new discoveries, enabling scientists to revisit old obse...

Dental Implants in Richmond: TUTH Dental Emphasizes the Importance of a Strong Foundation
TUTH Dental highlights that successful dental implants depend on adequate bone and healthy gum tissue, requiring individualized treatment planning tha...

Home-Based Neurorehabilitation Triples Therapy Dose, MindMaze Therapeutics Reports
MindMaze Therapeutics' multi-site program shows that home-based rehabilitation using MindMotion triples motor-training dose and improves functional ou...

Gerresheimer Achieves EcoVadis Gold Rating, Ranking in Top 5% Globally
Gerresheimer has improved its EcoVadis sustainability score to 82 out of 100, earning Gold recognition and placing it among the top 5% of rated compan...

Quantum BioPharma's FDA Clearance for Lucid-MS Opens New Frontier in Multiple Sclerosis Treatment
Quantum BioPharma (NASDAQ: QNTM) has received FDA approval to begin Phase 2 testing of Lucid-MS, a first-in-class multiple sclerosis drug that targets...

Nano-X Imaging Expands UK Access and Local AI Inference for Medical Imaging
Nano-X Imaging advances its AI-driven medical imaging strategy through an exclusive UK reseller agreement and optimization of its AI framework for on-...

SS Innovations Submits FDA Response for SSi Mantra Surgical Robot, Targeting U.S. Market Entry by 2027
SS Innovations has submitted its response to the FDA's request for additional information on its 510(k) submission for the SSi Mantra surgical robotic...

Scinai Immunotherapeutics Secures $4 Million Private Placement to Fuel CDMO Expansion and Immunotherapy Pipeline
Scinai Immunotherapeutics has raised approximately $4 million through a private placement and warrant inducement transaction, providing capital to exp...

MindBio Completes Manufacturing of AI Kiosk to Detect Intoxication by Voice
MindBio Therapeutics has completed manufacturing of its next-generation Edge AI Intoxication Detection Kiosk, which uses voice analytics to identify i...

MindBio Completes Manufacturing of AI Intoxication Detection Kiosk, Targeting Workplace Screening
MindBio Therapeutics has finished manufacturing its next-generation AI-powered intoxication detection kiosk, which uses voice analysis to screen for i...

AI and Advanced Imaging Set to Transform Breast Cancer Detection, with Survival Rates Reaching 90-100% When Caught Early
Artificial intelligence and next-generation imaging tools are poised to reshape breast cancer detection, enabling earlier diagnosis and personalized s...

Retension Pharmaceuticals Raises $45 Million in Upsized IPO to Advance Hypertension Treatment
Retension Pharmaceuticals' upsized $45 million IPO provides critical funding to complete a Phase 2b trial and prepare for a Phase 3 trial of its lead ...

Women in Wound Care Launches First Nonprofit to Elevate Women in Wound Care Science
Women in Wound Care launches as the first nonprofit dedicated to elevating women in wound care science, aiming to advance the science of healing throu...

Casago Founder Steve Schwab Walks 200 Miles to Fund Children's Medical Care in Mexico
Steve Schwab's 200.4-mile charity walk from Phoenix to Rocky Point aims to raise $70,000 for the Mexico Children's Foundation, highlighting the founda...

VERAXA Biotech's BiTAC-ADC Platform Shows First In Vivo Proof-of-Concept with Tumor Regression and Favorable Safety
VERAXA Biotech presented first in vivo proof-of-concept data for its BiTAC-ADC platform, demonstrating significant tumor regression in a breast cancer...

American Heart Association Names Five Finalists for 2026 Health Tech Competition
The American Heart Association's selection of five health technology finalists highlights a push to overcome adoption barriers and accelerate innovati...

SS Innovations Submits FDA Response for SSi Mantra Surgical Robot, Advancing U.S. Market Entry
SS Innovations has responded to the FDA's request for additional information on its SSi Mantra surgical robotic system, moving the device closer to U....

NanoViricides Advances Ebola Treatment Trial, Paving Way for Broader Antiviral Use
NanoViricides reports progress in its Phase IIA trial of NV-387 Oral Gummies for Ebola, potentially validating a broad-spectrum antiviral platform tha...

Eliminating 'Immune Fog' Shows Promise in Cancer Interception, But Challenges Remain
A UK study reveals a potential method to stop lung cancer before diagnosis by clearing immune fog, though some mice still developed cancer, highlighti...

NextPlat Expands Florida Healthcare Network with New PharmcoRx Pharmacy in Jacksonville
NextPlat Corp opens a new PharmcoRx community pharmacy in Jacksonville, Florida, expanding its healthcare operations and advancing its strategy of com...

Nutriband Raises $1.75 Million to Advance AVERSA Fentanyl Toward FDA Submission
Nutriband Inc. (NASDAQ: NTRB) raised approximately $1.75 million through warrant exercises, funding the remaining clinical development and New Drug Ap...

Scinai Immunotherapeutics Lands $5.1 Million CDMO Agreement, Committed Orders Surge 300%
Scinai Immunotherapeutics' CDMO subsidiary signed a $5.1 million development and clinical manufacturing deal with a U.S. biopharma company, driving to...

VERAXA Biotech's BiTAC-ADC Platform Shows Early Promise in Breast Cancer Model
VERAXA Biotech presented first in vivo proof-of-concept data for its BiTAC-ADC platform at the World ADC Congress, demonstrating significant tumor reg...

Leksum Inks Agreement with Medical University of Vienna for LK-ICU Clinical Trial Preparatory Work
Leksum LLC has signed an agreement with the Medical University of Vienna to conduct preparatory work for Phase I/II clinical trials of LK-ICU, a thera...

Glowise Consolidates GLP-1 Tracking into a Single App
Glowise, a new app from Vocalbeats.AI, brings medication reminders, food logs, hydration, side effects, and progress tracking into one platform, aimin...

SPRED2 Loss Drives Liver Cancer Stemness Through Newly Mapped p53/miR-506-3p/KLF4 Axis
A newly identified tumor-suppressive circuit linking SPRED2, p53, miR-506-3p, and KLF4 could offer fresh therapeutic targets for hepatocellular carcin...

Regentis Biomaterials' GelrinC Draws Surgeon Interest at ICRS Summit, Signaling Potential Shift in Cartilage Repair Market
Regentis Biomaterials reported strong surgeon engagement for its GelrinC hydrogel implant at the ICRS Summit, highlighting the potential for a new sta...

Regentis Biomaterials to Present at 2026 ThinkEquity Conference, Highlighting GelrinC Progress
Regentis Biomaterials will present at the 2026 ThinkEquity Conference, showcasing its GelrinC technology and recent clinical and regulatory advancemen...

Mitch Gould's Retail Journey: From Brooklyn Roots to Amazon's Sports Nutrition Aisle
Mitch Gould's decades-long career spanning Home Depot, Walmart, and Amazon illustrates how traditional distribution expertise remains essential in the...

DuLac Farmaceutici Pursues U.S. Retail Expansion After ECRM Meetings
DuLac Farmaceutici is advancing its U.S. retail strategy following productive meetings at the 2026 ECRM Vitamin, Weight Management & Sports Nutrition ...

Tropical Orthodontics Earns 10th Consecutive Consumer Choice Award, Signaling Sustained Patient Trust in Mississauga
Tropical Orthodontics has received the 2026 Consumer Choice Award for Business Excellence, marking ten straight years of recognition and underscoring ...

Earth Science Tech’s Vertical Integration and Dual-Market Strategy Position It for Scalable Growth
Earth Science Tech Inc. is building a self-sustaining healthcare business through vertical integration and a dual B2B/B2C model, with plans to expand ...

Masked High Blood Pressure Linked to 70% Higher Fall Risk in Adults Over 78
New research shows that masked hypertension, normal office blood pressure but high home readings, is associated with a 70% higher risk of falls compar...

Samsung's $80B Profit Surge Signals AI Memory Boom's Broad Economic Reach
Samsung's projected $80 billion quarterly profit, driven by AI memory chip demand, underscores the sector's explosive growth and its ripple effects ac...

Rising Flu Infections Signal Early Season, Highlight Need for Rapid Diagnostics
Flu cases are increasing across the U.S. earlier than usual, prompting health officials to recommend early vaccination and raising concerns about comm...

Newron Confronts FDA Clinical Hold Over Evenamide Safety Signal as Phase 3 Schizophrenia Program Advances
Newron Pharmaceuticals has received written feedback from the FDA on the clinical hold at U.S. study centers for its Phase 3 ENIGMA-TRS 2 trial, as th...

Verbio Pivots from Investment to Cash Flow at Capital Markets Day 2026
Verbio's Capital Markets Day 2026 marks a strategic shift from heavy investment to optimizing new capacity for sustainable value creation and sharehol...

